FDA recall D-0213-2018

Dr. Reddy's Laboratories, Inc. · Class II · drug

Product

Docetaxel Injection USP, 20 mg/mL, One-Vial Formulation, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046 INDIA, NDC 43598-611-11

Reason for recall

Defective Container: Product complaints received of defect in the seal of the Docetaxel injection vials that the aluminum seal and/or stopper is removed when the cap is flipped off.

Distribution

Distributed nationwide in the USA, Uzbekistan, and Myanmar

Key facts

Status
Terminated
Initiation date
2017-01-09
Report date
2018-01-17
Termination date
2018-12-04
Voluntary/Mandated
Voluntary: Firm initiated
Location
Princeton, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0213-2018